Search

Your search keyword '"Hengstler, Jan G."' showing total 566 results

Search Constraints

Start Over You searched for: Author "Hengstler, Jan G." Remove constraint Author: "Hengstler, Jan G." Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
566 results on '"Hengstler, Jan G."'

Search Results

5. Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease

8. The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects

11. Alterations in the hepatocyte epigenetic landscape in steatosis

12. Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

16. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis

18. Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation

21. Sublethal necroptosis signaling promotes inflammation and liver cancer

22. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

25. Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity

28. Evaluation of the genotoxic potential of acrylamide: Arguments for the derivation of a tolerable daily intake (TDI value)

30. Stellungnahme zu Acetaldehyd als Aromastoff: Aspekte der Risikobewertung

31. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells

33. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay

38. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling

40. Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury

42. Comparing in vitro human liver models to in vivo human liver using RNA-Seq

43. Integrated data from intravital imaging and HPLC–MS/MS analysis reveal large interspecies differences in AFB1 metabolism in mice and rats.

47. The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods

50. Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease

Catalog

Books, media, physical & digital resources